PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug Rankings

Drugs ranked by cost, safety signals, recalls, and shortages. All data from FDA, FAERS, and NADAC sources.

What These Rankings Show

PlainMeds tracks 6 ranking views derived from 682 prescription drugs, 3,720 FAERS adverse-event reports, 1,000 FDA enforcement recalls, and 1,679 active and resolved drug shortages. Cost-of-care leaderboards use CMS NADAC per-unit acquisition pricing, the actual price pharmacies pay before markup, across 23,166 monthly pricing records. Safety leaderboards aggregate FDA Adverse Event Reporting System volumes for total reports, death-associated reports, and hospitalization reports separately, so a drug high on report-volume need not be high on serious-outcome volume.

Ranking caveats: FAERS is a passive surveillance system, so widely-prescribed drugs accumulate reports faster than rarely-prescribed ones; rankings should be read as signal-detection indicators for further investigation, not per-patient risk scores. Recall rankings reflect manufacturer-batch enforcement actions, not aggregate severity. Shortage durations include both manufacturing-quality and active-ingredient supply causes, and a drug appearing on multiple lists (cost + recalls + shortages) usually points to concentrated-supplier or single-source manufacturing fragility rather than a single safety story. See the full methodology & limitations page for ranking logic and data vintage.

Most Expensive Drugs

Drugs with the highest NADAC cost per unit, the priciest medications on the market.

See all →
  1. 1 ustekinumab $26,794.63
  2. 2 risankizumab $20,211.78
  3. 3 guselkumab $13,350.90
  4. 4 secukinumab $7,206.70
  5. 5 golimumab $6,818.88

Most Adverse Event Reports

Drugs with the most FDA adverse event reports filed through FAERS.

See all →
  1. 1 adalimumab 695,825
  2. 2 etanercept 591,578
  3. 3 aspirin 518,554
  4. 4 prednisone 482,856
  5. 5 acetaminophen 417,458

Most Recalled Drugs

Drugs with the highest number of FDA recall actions.

See all →
  1. 1 testosterone 28
  2. 2 calcium carbonate 25
  3. 3 duloxetine 22
  4. 4 semaglutide 22
  5. 5 losartan 19

Most Death-Associated Reports

Drugs with the most FAERS reports where death was a reported outcome.

See all →
  1. 1 furosemide 60,624
  2. 2 acetaminophen 58,910
  3. 3 oxycodone 51,490
  4. 4 prednisone 50,090
  5. 5 aspirin 47,820

Most Hospitalization Reports

Drugs with the most FAERS reports involving hospitalization.

See all →
  1. 1 aspirin 203,341
  2. 2 furosemide 190,901
  3. 3 prednisone 166,315
  4. 4 acetaminophen 150,224
  5. 5 adalimumab 146,638

Longest Active Drug Shortages

Currently shorted drugs ranked by how long the shortage has persisted.

See all →
  1. 1 atropine 15+ yrs
  2. 2 fentanyl 15+ yrs
  3. 3 epinephrine 14+ yrs
  4. 4 lidocaine topical 14+ yrs
  5. 5 hydromorphone 9+ yrs

Related Sections

Browse Drugs 682 medications A-Z All Recalls 1,000 enforcement actions Active Shortages FDA shortage tracker Original Research Editorial analysis

Rankings Methodology

Rankings pull from federal data sources: CMS NADAC pricing for cost leaderboards, FDA FAERS for adverse-event volume, death-associated reports, and hospitalizations, FDA Enforcement Reports for recall counts, and FDA Drug Shortages Database for shortage duration. Raw counts reflect exposure volume and reporting practices, they are signal-detection indicators, not per-patient risk measures. See full methodology for ranking logic, limitations, and data vintage.

Source: U.S. Food and Drug Administration (FDA) - FAERS + recalls + NADAC openFDA aggregated drug data: FAERS, recalls, NADAC pricing, drug shortages · 2024 Rankings derived from FDA openFDA APIs across FAERS adverse events, drug recall enforcement reports, NADAC pricing, and drug shortages list.